Six Healthy Volunteers in Phase I Drug Trial-Critically Ill_UK
The Phase I trial–the first in humans–was set up by US drug research company Parexel International Corp on behalf of German pharmaceutical company TeGenero.
Grassley to HHS Secretary: OHRP calls Blood Experiment UNETHICAL, Unapprovable
In a blistering letter addressed to the Secretary of Health and Human Services, Senator Grassley calls upon Michael Leavitt to give “immediate attention” to the serious issues raised by a Northfield Laboratory, non-consensual artificial blood experiment.
Fix the Diagnosis, Not the Children
From both sides of the Atlantic, even psychiatrists are acknowledging–the ADHD diagnosis makes no sense.
OHRP Response to AHRP Complaint & AHRP Reply
Did OHRP conduct an investigation of the PolyHeme blood experiment and did OHRP issue a report of its findings?
AHRP Files Federal Complaint Re: Non-Consensual “Blood Substitute” Experiment on Trauma Patients
This controversial, commercial experiment is being conducted without informed consent in trauma patients who require blood to survive. PolyHeme is being tested in patients in ambulances and at hospital emergency facilities where these trauma patients are denied life-saving real blood.
Despite Undisclosed Deaths, 10 Heart Attacks FDA Allows Blood Substitute Experiment With No Conset
The Wall Street Journal reports: “The FDA is allowing Northfield [Laboratories, Inc] to test its blood substitute without the consent of the trauma patients, who often are unconscious.”
Scientific integrity: ?Truth? versus method
"This is a critical moment: if the system of peer-review is not any longer able to guarantee the reliability of scientific research, this means that science has lost its way."
Fight Was All About Scientific Integrity_Jonathan Fishbein
“Science has become so severely politicized that one has to be skeptical of nearly every research result that is reported.”
Chief Respiratory Care Mass General Hospital-Harvard-Rejects ARDS Recommendation
A critical editorial by Dr. Robert M Kacmarek, Head of Respiratory Care Services at Massachusetts General Hospital and professor at Harvard University—the coordinating center for the ARDS Network, calls into question the validity of the ARDS Network recommendation of treating all patients with ALI-ARDS with a fixed, low air ventilation setting (6 mL/ kg).
Analysis of S. 1873 – The Biodefense and Pandemic Vaccine and Drug Development Act of 2005
INTRODUCTION: This bill seriously endangers, if not completely undermines, the democratic process and the rule of law. It will absolutely destroy the unalienable rights of trial by jury and informed consent. It is a radical transfer of the US Treasury into the hands of unaccountable private companies whose record shows far more concern about profits than in protecting and improving the health of the American people. It also concentrates the power of life and death in the hands of one very fallible human being and creates an unaccountable federal bureaucracy not subject to disclosure, independent oversight or the safeguards of accountability necessary in a free republic.
Ethics, Conflict of Interest, first ever public response by David Healy, MD, to James Coyne, PhD, attack in AJOB
The Columbia lecture was originally scheduled as a debate between David Healy, MD and James Coyne, PhD. The debate did not take place, and Dr. Coyne subsequently lectured in Rutgers the following week. The lecture covered the main points Dr. Coyne makes in the e-mail below. Dr. Healy’s response follows….
Big Pharma’s Shameful Secret
"Every year, drug companies spend $14 billion to test experimental substances on humans. Across the U.S., the centers that do the testing–and the regulators who watch them–allow scores of human test subjects to be injured or killed."